CytoDyn Announces Treatment of the First Patient in its Pivotal Phase 3 COVID-19 Trial in Brazil for Patients with Severe Symptoms

Ads

You May Also Like

ABLYNX ANNOUNCES WARRANT EXERCISE

REGULATED INFORMATION GHENT, Belgium, 23 October 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] ...

BeiGene Announces Proposed Hong Kong Initial Public Offering and Global Offering

CAMBRIDGE, Mass. and BEIJING, China, July 27, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...